Eight top prescribers of Insys Therapeutics Inc.'s opioid spray accounted for more than $28 million in Medicare bills for the drug, an FBI witness testified Friday as federal prosecutors tried to show the doctors doled out prescriptions in exchange for lucrative speaking engagements.
A former Insys Therapeutics Inc. executive chucked his phone off the side of a mountain to get rid of communications about doctors, a Massachusetts federal jury heard Wednesday as the executive and four others stand trial for a scheme to bribe physicians to prescribe opioids.
Insys Therapeutics founder John Kapoor had a physical relationship with a sales representative who complained to him on several occasions about the structure of the company's speaker program, according to testimony by the former employee Tuesday as federal prosecutors continued their quest to prove Kapoor knew what was going on at all levels of his company.
A Boston federal jury is getting an incomplete impression in the racketeering trial of five former Insys Therapeutics executives because the company has refused to waive its attorney-client privilege, a judge said Monday as she reluctantly limited the scope of testimony by two upcoming witnesses.
An attorney for Insys Therapeutics founder John Kapoor asked a judge for a mistrial in Boston federal court Wednesday, saying a witness should not have been allowed to testify about how a heavy prescriber of Insys' fentanyl spray was also addicted to opioid painkillers himself.
A Florida pain doctor who was a heavy prescriber of Insys Therapeutics Inc.'s fentanyl spray was addicted to fentanyl-based drugs himself, a former Insys employee testified Tuesday in Boston federal court during the racketeering trial of five former company executives.
A former Insys Therapeutics sales manager was denied a mistrial Friday by a Massachusetts federal judge, who ruled that "salacious" testimony about the company allegedly discovering topless photos of her online was admitted not for its truth or lack thereof, but rather because it was relevant in the context of the racketeering trial.
The cross-examination of a key witness in the Insys racketeering trial led to defiant testimony and reprimands in Boston federal court Thursday as the former company executive veered from a defense attorney's questions to emphasize his belief that Insys founder John Kapoor was the driving force behind an alleged bribery scheme.
Insys Therapeutics Inc. founder John Kapoor demanded loyalty above integrity from his sales reps since it meant they would be willing to pay off doctors to prescribe an expensive Insys opioid spray, a former company vice president testified Wednesday at a Massachusetts federal court racketeering trial.
The former head of sales at Insys Therapeutics told a Boston federal jury Tuesday that the company's founder, John Kapoor, was a micromanager who analyzed daily data about doctors' prescribing habits, prompting the sales team to take swift action whenever a doctor started writing prescriptions for a competitor.